2025 - Optimizing Patient Adherence in Clinical Trials: The Science of Risk Identification and Personalized Digital Interventions
Date2025-05-09
Deadline2025-05-09
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Patient Recruitment & Retention
- Global Clinical Trials Connect 2025
- 12th International Conference on Clinical Trials
- Adaptive by Design: How RTSM Powers Early-Phase Clinical Trial Success
- Risk-Based Quality Management (RBQM): The Connective Tissue for Clinical Data Quality
- Redefining Women’s Cancer Care: Delivering Smarter, Safer Clinical Trials
Topics/Call fo Papers
The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly, treatment adherence and engagement in study protocols are critical for clinical trial success.
Every research participant who discontinues study drug, fails to provide clinical data, or drops out of a study, reduces its statistical power, and may bias the results, impacting credibility. In this webinar, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting.
The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research.
Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful, effective approaches should apply the findings from behavioral science, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial, a valid assessment of patients’ beliefs, attitudes and behaviors allows for rational and personalized interventions, including solutions using digital tools.
Register for this webinar today to explore how evidence-based behavioral frameworks, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials.
Keywords: Clinical Trials, Drug Development, Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Patient Engagement, Risk Management, Clinical Trial Design, Clinical Study Design, Patient Diversity
Every research participant who discontinues study drug, fails to provide clinical data, or drops out of a study, reduces its statistical power, and may bias the results, impacting credibility. In this webinar, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting.
The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research.
Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful, effective approaches should apply the findings from behavioral science, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial, a valid assessment of patients’ beliefs, attitudes and behaviors allows for rational and personalized interventions, including solutions using digital tools.
Register for this webinar today to explore how evidence-based behavioral frameworks, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials.
Keywords: Clinical Trials, Drug Development, Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Patient Engagement, Risk Management, Clinical Trial Design, Clinical Study Design, Patient Diversity
Other CFPs
- Unlocking the Future of Gene Editing: Key Concepts and Breakthroughs in CRISPR
- Biotech Commercialization: Strategic Insights for Asset Development, Deal-Making and Market Access
- Adaptive by Design: How RTSM Powers Early-Phase Clinical Trial Success
- Optimizing Drug Loading in Amorphous Solid Dispersions: Maximizing Bioavailability While Minimizing Pill Burden
- Risk-Based Quality Management (RBQM): The Connective Tissue for Clinical Data Quality
Last modified: 2025-04-02 05:23:14